Annual Accounts Payable
$92.33 M
-$9.77 M-9.57%
December 31, 2023
Summary
- As of February 26, 2025, IART annual accounts payable is $92.33 million, with the most recent change of -$9.77 million (-9.57%) on December 31, 2023.
- During the last 3 years, IART annual accounts payable has risen by +$37.72 million (+69.07%).
- IART annual accounts payable is now -18.36% below its all-time high of $113.09 million, reached on December 31, 2019.
Performance
IART Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$77.67 M
-$29.83 M-27.75%
September 30, 2024
Summary
- As of February 26, 2025, IART quarterly accounts payable is $77.67 million, with the most recent change of -$29.83 million (-27.75%) on September 30, 2024.
- Over the past year, IART quarterly accounts payable has dropped by -$15.88 million (-16.98%).
- IART quarterly accounts payable is now -31.32% below its all-time high of $113.09 million, reached on December 31, 2019.
Performance
IART Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
IART Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.6% | -17.0% |
| 3 y3 years | +69.1% | -17.0% |
| 5 y5 years | +21.4% | -17.0% |
IART Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -9.6% | +49.3% | -31.1% | +25.6% |
| 5 y | 5-year | -18.4% | +69.1% | -31.3% | +54.5% |
| alltime | all time | -18.4% | >+9999.0% | -31.3% | >+9999.0% |
Integra LifeSciences Holdings Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $77.67 M(-27.7%) |
| Jun 2024 | - | $107.49 M(+13.9%) |
| Mar 2024 | - | $94.40 M(+2.2%) |
| Dec 2023 | $92.33 M(-9.6%) | $92.33 M(-1.3%) |
| Sep 2023 | - | $93.55 M(-6.2%) |
| Jun 2023 | - | $99.77 M(-11.5%) |
| Mar 2023 | - | $112.78 M(+10.5%) |
| Dec 2022 | $102.10 M(+65.1%) | $102.10 M(+26.5%) |
| Sep 2022 | - | $80.73 M(+16.2%) |
| Jun 2022 | - | $69.50 M(-21.4%) |
| Mar 2022 | - | $88.37 M(+42.9%) |
| Dec 2021 | $61.84 M(+13.2%) | $61.84 M(+3.8%) |
| Sep 2021 | - | $59.60 M(-9.0%) |
| Jun 2021 | - | $65.51 M(+6.5%) |
| Mar 2021 | - | $61.50 M(+12.6%) |
| Dec 2020 | $54.61 M(-51.7%) | $54.61 M(+8.7%) |
| Sep 2020 | - | $50.25 M(-13.8%) |
| Jun 2020 | - | $58.29 M(-39.9%) |
| Mar 2020 | - | $97.06 M(-14.2%) |
| Dec 2019 | $113.09 M(+48.7%) | $113.09 M(+20.1%) |
| Sep 2019 | - | $94.16 M(-12.2%) |
| Jun 2019 | - | $107.19 M(+6.6%) |
| Mar 2019 | - | $100.55 M(+32.2%) |
| Dec 2018 | $76.05 M(-19.1%) | $76.05 M(-12.0%) |
| Sep 2018 | - | $86.38 M(+2.8%) |
| Jun 2018 | - | $84.04 M(-3.4%) |
| Mar 2018 | - | $87.00 M(-7.4%) |
| Dec 2017 | $93.97 M(+223.4%) | $93.97 M(+130.7%) |
| Sep 2017 | - | $40.74 M(-3.4%) |
| Jun 2017 | - | $42.19 M(-7.5%) |
| Mar 2017 | - | $45.59 M(+56.9%) |
| Dec 2016 | $29.06 M(-16.4%) | $29.06 M(-25.4%) |
| Sep 2016 | - | $38.93 M(-11.4%) |
| Jun 2016 | - | $43.95 M(-18.6%) |
| Mar 2016 | - | $53.99 M(+55.3%) |
| Dec 2015 | $34.77 M(+20.5%) | $34.77 M(-9.9%) |
| Sep 2015 | - | $38.59 M(-33.7%) |
| Jun 2015 | - | $58.20 M(+36.5%) |
| Mar 2015 | - | $42.63 M(+47.7%) |
| Dec 2014 | $28.87 M(-43.1%) | $28.87 M(-37.2%) |
| Sep 2014 | - | $45.94 M(-2.3%) |
| Jun 2014 | - | $47.00 M(+1.2%) |
| Mar 2014 | - | $46.43 M(-8.5%) |
| Dec 2013 | $50.75 M(+38.1%) | $50.75 M(-6.8%) |
| Sep 2013 | - | $54.47 M(+21.7%) |
| Jun 2013 | - | $44.77 M(+2.0%) |
| Mar 2013 | - | $43.88 M(+19.4%) |
| Dec 2012 | $36.74 M(+32.9%) | $36.74 M(-15.0%) |
| Sep 2012 | - | $43.24 M(+0.1%) |
| Jun 2012 | - | $43.19 M(+21.4%) |
| Mar 2012 | - | $35.58 M(+28.7%) |
| Dec 2011 | $27.66 M(-0.5%) | $27.66 M(-22.0%) |
| Sep 2011 | - | $35.48 M(-25.9%) |
| Jun 2011 | - | $47.89 M(+35.6%) |
| Mar 2011 | - | $35.31 M(+27.1%) |
| Dec 2010 | $27.78 M | $27.78 M(-20.0%) |
| Sep 2010 | - | $34.72 M(+5.5%) |
| Jun 2010 | - | $32.91 M(+29.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | $25.40 M(+3.3%) |
| Dec 2009 | $24.60 M(+7.1%) | $24.60 M(+20.9%) |
| Sep 2009 | - | $20.34 M(+2.2%) |
| Jun 2009 | - | $19.90 M(-12.9%) |
| Mar 2009 | - | $22.83 M(-0.6%) |
| Dec 2008 | $22.96 M(-1.2%) | $22.96 M(-12.0%) |
| Sep 2008 | - | $26.08 M(+0.2%) |
| Jun 2008 | - | $26.03 M(-1.3%) |
| Mar 2008 | - | $26.36 M(+13.5%) |
| Dec 2007 | $23.23 M(+14.3%) | $23.23 M(-13.7%) |
| Sep 2007 | - | $26.93 M(+4.3%) |
| Jun 2007 | - | $25.83 M(+34.1%) |
| Mar 2007 | - | $19.25 M(-5.3%) |
| Dec 2006 | $20.33 M(+126.4%) | $20.33 M(+25.1%) |
| Sep 2006 | - | $16.25 M(+0.4%) |
| Jun 2006 | - | $16.19 M(+61.1%) |
| Mar 2006 | - | $10.05 M(+12.0%) |
| Dec 2005 | $8.98 M(-11.6%) | $8.98 M(-1.5%) |
| Sep 2005 | - | $9.12 M(-28.7%) |
| Jun 2005 | - | $12.79 M(-12.1%) |
| Mar 2005 | - | $14.54 M(+43.1%) |
| Dec 2004 | $10.16 M(+27.8%) | $10.16 M(+21.9%) |
| Sep 2004 | - | $8.33 M(+25.7%) |
| Jun 2004 | - | $6.63 M(-3.6%) |
| Mar 2004 | - | $6.88 M(-13.5%) |
| Dec 2003 | $7.95 M(+111.1%) | $7.95 M(+20.3%) |
| Sep 2003 | - | $6.60 M(+42.9%) |
| Jun 2003 | - | $4.62 M(+7.1%) |
| Mar 2003 | - | $4.31 M(+14.6%) |
| Dec 2002 | $3.76 M(+28.7%) | $3.76 M(+0.7%) |
| Sep 2002 | - | $3.74 M(+25.0%) |
| Jun 2002 | - | $2.99 M(-0.2%) |
| Mar 2002 | - | $3.00 M(+2.4%) |
| Dec 2001 | $2.92 M(-13.1%) | $2.92 M(-20.9%) |
| Sep 2001 | - | $3.70 M(+2.7%) |
| Jun 2001 | - | $3.60 M(-1.4%) |
| Mar 2001 | - | $3.65 M(+8.6%) |
| Dec 2000 | $3.36 M(+238.3%) | $3.36 M(-9.4%) |
| Sep 2000 | - | $3.71 M(+49.1%) |
| Jun 2000 | - | $2.49 M(+45.0%) |
| Mar 2000 | - | $1.72 M(+72.7%) |
| Dec 1999 | $994.00 K(+65.7%) | $994.00 K(-23.5%) |
| Sep 1999 | - | $1.30 M(-23.5%) |
| Jun 1999 | - | $1.70 M(-29.2%) |
| Mar 1999 | - | $2.40 M(+300.0%) |
| Dec 1998 | $600.00 K(+20.0%) | $600.00 K(+20.0%) |
| Sep 1998 | - | $500.00 K(+25.0%) |
| Jun 1998 | - | $400.00 K(+33.3%) |
| Mar 1998 | - | $300.00 K(-40.0%) |
| Dec 1997 | $500.00 K(+400.0%) | $500.00 K(-54.5%) |
| Sep 1997 | - | $1.10 M(+450.0%) |
| Jun 1997 | - | $200.00 K(-50.0%) |
| Mar 1997 | - | $400.00 K(+300.0%) |
| Dec 1996 | $100.00 K(-66.7%) | $100.00 K(-66.7%) |
| Sep 1996 | - | $300.00 K(-25.0%) |
| Jun 1996 | - | $400.00 K(0.0%) |
| Mar 1996 | - | $400.00 K(+33.3%) |
| Dec 1995 | $300.00 K | $300.00 K(-57.1%) |
| Sep 1995 | - | $700.00 K |
FAQ
- What is Integra LifeSciences Holdings annual accounts payable?
- What is the all time high annual accounts payable for Integra LifeSciences Holdings?
- What is Integra LifeSciences Holdings annual accounts payable year-on-year change?
- What is Integra LifeSciences Holdings quarterly accounts payable?
- What is the all time high quarterly accounts payable for Integra LifeSciences Holdings?
- What is Integra LifeSciences Holdings quarterly accounts payable year-on-year change?
What is Integra LifeSciences Holdings annual accounts payable?
The current annual accounts payable of IART is $92.33 M
What is the all time high annual accounts payable for Integra LifeSciences Holdings?
Integra LifeSciences Holdings all-time high annual accounts payable is $113.09 M
What is Integra LifeSciences Holdings annual accounts payable year-on-year change?
Over the past year, IART annual accounts payable has changed by -$9.77 M (-9.57%)
What is Integra LifeSciences Holdings quarterly accounts payable?
The current quarterly accounts payable of IART is $77.67 M
What is the all time high quarterly accounts payable for Integra LifeSciences Holdings?
Integra LifeSciences Holdings all-time high quarterly accounts payable is $113.09 M
What is Integra LifeSciences Holdings quarterly accounts payable year-on-year change?
Over the past year, IART quarterly accounts payable has changed by -$15.88 M (-16.98%)